Ticker Report United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 7,802 shares of the company's stock in a transaction on Monday, September 9th. The shares were sold at an average price...\n more…
Ticker Report Acadian Asset Management LLC trimmed its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 79.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 22,590 shares of...\n more…
Business Wire United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its 2024 Corporate Responsibility and Public Benefit Report (Report) covering its FY...\n more…
Ticker Report Savant Capital LLC trimmed its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 1.2% in the second quarter, according to its most recent filing with the Securities and...\n more…
Ticker Report Arizona State Retirement System decreased its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 5.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 12,281...\n more…
Ticker Report CIBC Asset Management Inc increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 17.9% in the 2nd quarter, according to its most recent 13F filing with the Securities...\n more…